Cas:91653-50-8 Zingiberensis saponin I manufacturer & supplier

Chemical Name:Zingiberensis saponin I

CAS.NO:91653-50-8

Synonyms:Zingiberensis new saponin;β-D-Glucopyranoside, (3β,25R)-spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-β-D-glucopyranosyl-(1→3)-β-D-glucopyranosyl-(1→4)]-;Spiro[8H-naphth[2′,1′:4,5]indeno[2,1-b]furan-8,2′-[2H]pyran], β-D-glucopyranoside deriv.;Spirostan, β-D-glucopyranoside deriv.;Hexopyranoside, spirost-5-en-2-yl O–6-deoxyhexopyranosyl-(1->2)-O-[O-hexopyranosyl-(1->3)hexopyranosyl-(1->4)]-;3-O-β-D-Glucopyranosyl(1→3)-β-D-glucopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-β-D-glucopyranoside-diosgenin;3-O–D-Glucopyranosyl-(13)–D-glucopyranosyl-(14)-[-L-rhamnopyranosyl-(12)]–D-glucopyranosyldiosgenin;Zingiberensis newsaponin;Spirost-5-en-2-yl 6-deoxyhexopyranosyl-(1->2)-[hexopyranosyl-(1->3)hexopyranosyl-(1->4)]hexopyranoside;3-O-β-D-Glucopyranosyl-(1→3)-β-D-glucopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranosyldiosgenin;Zingiberennewsaponin;Diosgenin 3-O–D-Glucopyranosyl-(13)–D-glucopyranosyl-(14)-[-L-rhamnopyranosyl-(12)]–D-glucopyra;Zingiberensis saponin I

Molecular Formula:C₅₁H₈₂O₂₂

Molecular Weight:1047.184

HS Code:

Physical and Chemical Properties:

Melting point:285-287 °C (methanol)

Boiling point:N/A

Density:1.5±0.1 g/cm3

Index of Refraction:1.637

PSA:335.06000

Exact Mass:1046.529785

LogP:4.38

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Zingiberensis new saponin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Zingiberensis saponin I physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Zingiberensis new saponin Use and application,3)hexopyranosyl-(1-&gt technical grade,usp/ep/jp grade.

Related News: But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. Zingiberensis saponin I manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. Zingiberensis saponin I supplier As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. Zingiberensis saponin I vendor The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation. Zingiberensis saponin I factory But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed.